An Artificial Intelligence platform for biomarkers, drug development and personalized medicine
Cancer: a global problem
Cancer is a global problem and the identification of novel therapies is an urgent need. Unfortunately, drug development is a long lasting and expensive process with a high risk of failure.
Incorporation of targeted therapies challenge physicians and healthcare providers to adapt their systems to provide an easy and sustainable access to personalize medicine.
Better medicines for a personalized care
CancerAppy aims to resolve this problem by de-escalating the risk of drug development helping healthcare providers to optimize and improve their services.
By using big data, machine learning and biology at a global scale, CancerAppy seeks to enable better medicines for a personalized care.
We do work at four different scales in an integrated manner by using global biology data, therapeutic structural efficacy information, machine learning and real world patient data.
Our style: Where science meets artificial intelligence
Our team at CancerAppy is highly diversified, with practical experience, profound knowledge and subject matter expertise in oncology research, patient care and computer science. This enables us to provide cutting edge solutions, using science and artificial intelligence, at a global scale to hospitals, academic institutions, pharmaceutical companies and a wide range of players involved in patient care and cancer research.
Transforming the world of cancer research
With our platform we fill the gap between basic data and pharma intelligence tools. Our mission is to empower scientists, researchers, physicians and healthcare providers with the global benchmark in cancer research and patient treatment. This will let us transform the world of cancer research and eventually improve the lives of millions of people, globally.
Request an online test
We would be happy to show you our platform.
Find us at:
GeneReport
CancerAppy is pleased to announce that some new applications are now available in their proprietary platform. One of them is the GeneReport tool, a personalized treatment matched application, that permits score predicted treatments with patient genomic actionable...
SOSA – BEAZ program
This year 2021 starts very strong for Cancerappy. "Our project has been selected for the SOSA Tel Aviv-Beaz Bizkaia acceleration program." Hopefully, and as long as the covid19 let us, in May we will be in Tel Aviv developing our skills and networking with local...
Cancerappy awarded the prize for entrepreneurial initiative
Award #Premiosanjuan20 for Cancerappy… and its investors. In this month the emblematic San Juan 2020 Awards of the Albacete Business Association took place in which, this year, Luis Martín, our CEO and Co-founder of Cancerappy, has been awarded the prize for...